Arab Journal of Gastroenterology
Volume 10, Issue 4 , Pages 151-154 , December 2009

Metastatic gastrointestinal stromal tumours of the stomach: A report on two cases and literature review

Received 7 October 2009 ,Accepted 19 October 2009.

References 

  1. Fletcher CD, Berman JJ, Corless C, et al. Diagnosis of gastrointestinal stromal tumors: a consensus approach. Hum Pathol. 2002;33(5):459–465
  2. Jemal A, Murray T, Ward E, et al. Cancer statistics, 2005. CA Cancer J Clin. 2005;55(1):10–30
  3. Mazur MT, Clark HB. Gastric stromal tumors. Reappraisal of histogenesis. Am J Surg Pathol. 1983;7(6):507–519
  4. Kindblom LG, Remotti HE, Aldenborg F, et al. Gastrointestinal pacemaker cell tumor (GIPACT): gastrointestinal stromal tumors show phenotypic characteristics of the interstitial cells of Cajal. Am J Pathol. 1998;152(5):1259–1269
  5. Hirota S, Isozaki K, Moriyama Y, et al. Gain-of-function mutations of c-kit in human gastrointestinal stromal tumors. Science. 1998;279(5350):577–580
  6. Fleischman RA. From white spots to stem cells: the role of the kit receptor in mammalian development. Trends Genet. 1993;9(8):285–290
  7. Rubin BP, Singer S, Tsao C, et al. KIT activation is a ubiquitous feature of gastrointestinal stromal tumors. Cancer Res. 2001;61(22):8118–8121
  8. Heinrich MC, Corless CL, Duensing A, et al. PDGFRA activating mutations in gastrointestinal stromal tumors. Science. 2003;299(5607):708–710
  9. Corless C, Fletcher J, Heinrich M. Biology of gastrointestinal tumors. J Clin Oncol. 2004;22:3813–3825
  10. Sircar K, Hewlett BR, Huizinga JD, et al. Interstitial cells of Cajal as precursors of gastrointestinal stromal tumors. Am J Surg Pathol. 1999;23(4):377–389
  11. Thuneberg L. Interstitial cells of Cajal: intestinal pacemaker cells?. Adv Anat Embryol Cell Biol. 1982;71:1–130
  12. Hagger R, Finlayson C, Jeffrey I, et al. Role of the interstitial cells of Cajal in the control of gut motility. Br J Surg. 1997;84(4):445–450
  13. Bauer S, Corless CL, Heinrich MC, et al. Response to imatinib mesylate of a gastrointestinal stromal tumor with very low expression of KIT. Cancer Chemother Pharmacol. 2003;51(3):261–265
  14. Chompret A, Kannengiesser C, Barrois M, et al. PDGFRA germline mutation in a family with multiple cases of gastrointestinal stromal tumor. Gastroenterology. 2004;126(1):318–321
  15. Carney JA. Gastric stromal sarcoma, pulmonary chondroma and extra-adrenal paraganglioma (carney triad): natural history, adrenocortical component and possible familial occurrence. Mayo Clin Proc. 1999;74(6):543–552
  16. Roberts PJ, Eisenberg B. Clinical presentation of gastrointestinal stromal tumors and treatment of operable disease. Eur J Cancer. 2002;38(Suppl 5):S37–S38
  17. Rader AE, Avery A, Wait CL, et al. Fine-needle aspiration biopsy diagnosis of gastrointestinal stromal tumors using morphology, immunocytochemistry and mutational analysis of c-kit. Cancer. 2001;93(4):269–275
  18. Stroobants S, Goeminne J, Seegers M, et al. 18FDG-positron emission tomography for the early prediction of response in advanced soft tissue sarcoma treated with imatinib mesylate (glivec). Eur J Cancer. 2003;39(14):2012–2020
  19. Miettinen M, El Rifai W, Sobin HL, et al. Evaluation of malignancy and prognosis of gastrointestinal stromal tumors: a review. Hum Pathol. 2002;33(5):478–483
  20. DeMatteo RP, Lewis JJ, Leung D, et al. Two hundred gastrointestinal stromal tumors: recurrence patterns and prognostic factors for survival. Ann Surg. 2000;231(1):51–58
  21. Joensuu H, Fletcher C, Dimitrijevic S, et al. Management of malignant gastrointestinal stromal tumours. Lancet Oncol. 2002;3(11):655–664
  22. Crosby JA, Catton CN, Davis A, et al. Malignant gastrointestinal stromal tumors of the small intestine: a review of 50 cases from a prospective database. Ann Surg Oncol. 2001;8(1):50–59
  23. Pierie JP, Choudry U, Muzikansky A, et al. The effect of surgery and grade on outcome of gastrointestinal stromal tumors. Arch Surg. 2001;136(4):383–389
  24. Demetri GD, von Mehren M, Blanke CD, et al. Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors. N Engl J Med. 2002;347(7):472–480

PII: S1687-1979(09)00273-1

doi: 10.1016/j.ajg.2009.10.005

Arab Journal of Gastroenterology
Volume 10, Issue 4 , Pages 151-154 , December 2009

Article Tools

* Image Usage & Resolution